Continue reading Hill Street Appoints New Chairman of the Board
Hill Street Beverages
Hill Street Announces Closing of Asset Acquisition of Lexaria Canpharm
Hill Street Announces Definitive Agreement to Acquire Assets of Lexaria Canpharm, and Closing of Private Placement
Companies to continue both operational and research partnership for ten years
Continue reading Hill Street Announces Definitive Agreement to Acquire Assets of Lexaria Canpharm, and Closing of Private PlacementHill Street Beverage acquires global rights to Lexaria Bioscience’s THC assets for $3.85M; completes private placement
The transaction gives Hill Street exclusive global rights in perpetuity to Lexaria’s DehydraTECH technology to make products that contain THC and other psychoactive cannabinoids.
Continue reading Hill Street Beverage acquires global rights to Lexaria Bioscience’s THC assets for $3.85M; completes private placementHill Street Reports FY2020 Year End Results and Provides Update on Operations
Hill Street Beverage’s Hill Avenue Cannabis launch line-up of Cannabis Infused Beverages
Hill Street Beverage Company (CVE: BEER) CEO Terry Donnelly joined Steve Darling from Proactive with news, the company has launched Hill Avenue Cannabis Co. and a line-up of cannabis-infused beverages.
Continue reading Hill Street Beverage’s Hill Avenue Cannabis launch line-up of Cannabis Infused BeveragesHill Street Signs Agreement with Molecule to Produce Cannabis Infused Beverages
Toronto, Ontario – (Newsfile Corp. – October 15, 2020) – Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company“), announces that it has signed a non-binding Term Sheet with Molecule Holdings Inc. (CSE: MLCL) to produce select cannabis infused beverages for Hill Avenue Cannabis Co., the wholly owned subsidiary of Hill Street created to manage its business in the legal cannabis segment.
Continue reading Hill Street Signs Agreement with Molecule to Produce Cannabis Infused Beverages
